Flex Conference (Physical / Digital)

International Conference on Metabolic Enzymes and Drug Development - (ICMEDD-27)

31st - 1st April 2027 , Copenhagen - Denmark

Registration Options

Access Flexible Participation Categories

Call For Papers

The (ICMEDD-27) emphasizes interdisciplinary collaboration by bringing together experts from diverse fields. It encourages research that integrates multiple perspectives to address complex global challenges.

Key areas such as Metabolism are explored to promote cross-domain knowledge exchange and collaborative innovation.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Metabolic enzymes in drug discovery
  • Targeting metabolic pathways in cancer therapy
  • Role of enzymes in drug metabolism
  • Innovations in enzyme-based therapeutics
  • Biotechnology applications in enzyme development
  • Enzyme inhibitors in metabolic diseases
  • Metabolic profiling for drug development
  • Enzyme engineering for pharmaceutical applications
  • Natural products as enzyme inhibitors
  • Clinical trials of enzyme-based drugs
  • Enzyme replacement therapies for metabolic disorders
  • Regulatory challenges in enzyme therapeutics
  • Metabolic enzymes in personalized medicine
  • High-throughput screening of enzymes
  • Enzyme kinetics and drug interactions
  • Synthetic biology in enzyme production
  • Enzyme stability and formulation strategies
  • Emerging trends in enzyme research
  • Enzymatic assays in drug development
  • Future perspectives on metabolic enzymes

Assessment

All submissions will undergo peer review to ensure quality and interdisciplinary relevance. Accepted papers will be presented and considered for publication in journals and conference proceedings.

Registration

Registering for the conference provides access to keynote sessions, technical presentations, and networking opportunities with global experts.

Publication

Publishing through the conference enhances the visibility of your research and connects your work with a broader academic audience.